The Arkansas Children’s Research Institute, located on the campus of Arkansas Children’s Hospital, spent 18 years working on the drug Palforzia, […]
Stacie M. Jones, M.D., is Professor and Chief of Allergy and Immunology at the University of Arkansas for Medical Sciences […]
Aimmune announced the U.S. FDA has approved Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp], making this the first approved treatment for […]
The U.S. Food and Drug Administration approved Aimmune Therapeutics’ Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] to mitigate allergic reactions, including anaphylaxis, that may […]
Analysts have put the cost at $4,200 a year
In an issue of The Journal of Allergy and Clinical Immunology, a study was published that proved regular oral immunotherapy […]
Aimmune Therapeutics announced the phase 3 European clinical trial of AR101 for the treatment of peanut allergy, known as ARTEMIS […]
Kate Stromquist writing in the Northwest Arkansas Democrat Gazette reports on the local hope a global clinical trial brings to […]
BACKGROUND Peanut allergy, for which there are no approved treatment options, affects patients who are at risk for unpredictable and […]